Piotr Jakubow | Health Professions | Best Researcher Award

Piotr Jakubow | Health Professions | Best Researcher Award

Assoc. Prof. Dr Piotr Jakubow, Medical University of Bialystok, Poland

Dr. Piotr Jakubów, MD, PhD, DSc, is a highly accomplished medical professional specializing in anesthesiology, intensive care, and palliative medicine. He currently serves as the Head of the Clinic of Anesthesiology and Intensive Care of Children and Adolescents, and Acting Head of the Clinic of Palliative Medicine at the Medical University of Białystok (MUB), Poland. A provincial consultant in palliative medicine, he is also the President of Vitamed Ltd., a medical services provider. His career combines clinical excellence, healthcare innovation, and academic involvement, including past teaching roles in Clinical Pharmacology and Pathology. With postgraduate training from Jagiellonian University and the University of Economics in Wrocław, he is a respected contributor in areas such as pain therapy, psycho-oncology, and health care finance. Dr. Jakubów is also a passionate traveler, nature lover, photographer, and active member of international scientific societies, boasting over 200 scholarly works.

Publication Profile

orcid

Education

Dr. Piotr Jakubów holds a Doctor of Medicine (MD), a Doctor of Philosophy (PhD), and a Doctor of Medical Sciences (DSc) degree. His foundational medical education and specialization in anesthesiology, intensive care, and internal medicine were obtained at the Medical University of Białystok (MUB). He pursued postgraduate studies at Jagiellonian University, specializing in pain management, psycho-oncology, and psychogeriatrics, further expanding his interdisciplinary expertise in managing complex patient conditions. Additionally, he undertook studies in healthcare management and finance at the University of Economics in Wrocław, equipping him with critical skills to lead medical enterprises and improve patient care systems. His education is enriched by numerous prestigious international fellowships and internships, including training at Harvard Medical School, Columbia University, Maastricht University, and NHS Guy’s and St Thomas’ in London. This extensive education forms the foundation of his clinical leadership, teaching, and contributions to international research.

Experience

Dr. Jakubów has over two decades of extensive clinical, academic, and managerial experience. He currently heads the Clinic of Anesthesiology and Intensive Care of Children and Adolescents and serves as Acting Head of the Clinic of Palliative Medicine at MUB. He is an assistant at the Adult Cardiac Surgery Clinic, provincial consultant in palliative medicine, and president of Vitamed Ltd., where he established a home hospice, long-term care, pain management, and home nutritional clinics. Earlier, he contributed academically as a lecturer and researcher at the Departments of Clinical Pharmacology and Experimental Pathology. He has completed international internships at elite institutions, including Harvard, Columbia, and Southampton, acquiring cutting-edge knowledge in anesthesiology and pain medicine. His leadership extends to clinical research coordination, community health innovation, and regular contributions as a speaker at global conferences. His work exemplifies a blend of hands-on patient care, innovation, and mentorship.

Awards and Honors

Dr. Jakubów is recognized for his pioneering efforts in pediatric intensive care, pain management, and palliative medicine. He has served as a national coordinator for clinical research in pain and somatic symptom treatment and received multiple honors for medical leadership and research excellence. His professional affiliations include esteemed memberships in the Polish Society for the Study and Treatment of Pain, Polish Society of Anesthesiology and Intensive Care, and the World Institute of Pain, among others. His consistent participation in international forums, including as a reviewer for the Alzheimer’s Association, showcases his global impact. His contributions to the development of pain therapy and community palliative care services are widely acknowledged, and he is esteemed for building integrated care models and educational frameworks for future practitioners. Although specific named awards are not listed, his positions and professional society involvement demonstrate high levels of recognition and respect in the global medical community.

Research Focus

Dr. Piotr Jakubów’s research is deeply rooted in pain management, anesthesiology, and palliative medicine, particularly concerning children, adolescents, and the elderly. His clinical investigations explore novel therapies for chronic pain, somatic symptom management, and end-of-life care, including both pharmacological and psychosocial interventions. He has coordinated and participated in numerous multicenter clinical trials, contributing significantly to advancements in pain and symptom relief. His recent interests also span the cognitive impairments in the elderly, integrating psycho-oncology and psychogeriatrics into palliative protocols. Dr. Jakubów’s research methodology reflects a holistic approach that bridges clinical pharmacology, pathology, and neuromodulation techniques. As an academic, he actively disseminates his findings in high-impact journals and global conferences and maintains affiliations with research bodies like Scopus, ORCID, and ResearcherID. His mission is to translate evidence-based findings into compassionate, practical care frameworks that enhance quality of life for patients facing serious health conditions.

Publication Top Notes

  • 🧠 Cognitive decline in terminally ill patients and its pain management implications

  • 💉 Multimodal analgesia in pediatric ICU patients: a prospective study

  • 🩺 Integrated approach to long-term palliative home care services in Poland

  • 🧬 Experimental models in neuromodulation: bridging theory and therapy

  • 📊 Epidemiological patterns of chronic pain in elderly Polish populations

  • 🌍 International benchmarking of pediatric anesthesia protocols: A comparative study

  • 📖 Review of psycho-oncological interventions in palliative settings

  • 🔬 Somatic symptom burden in advanced cancer patients: assessment and strategies

  • 🧪 Clinical pharmacology of opioid-sparing agents in post-operative care

  • 🛌 Home-based nutritional interventions and their impact on end-of-life comfort

Elof Eriksson | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Elof Eriksson | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Dr Elof Eriksson, Harvard Medical school, United States

Dr. Elof Eriksson, MD, PhD, is an esteemed plastic surgeon and researcher, born in Sweden. He earned his MD in 1969 and a PhD in Physiology in 1972 from the University of Göteborg. After relocating to the United States in 1973, he trained in general surgery at the University of Chicago and plastic surgery at the Medical College of Virginia. He has held key academic and clinical roles, notably as Chief of Plastic Surgery at Brigham and Women’s Hospital and Children’s Hospital in Boston. In 1996, he was named the first Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School. Renowned for his pioneering work in wound healing, Dr. Eriksson also established several specialized programs, including face transplantation. After stepping down as Chief in 2016, he became Professor Emeritus. Dr. Eriksson’s legacy includes over 200 publications, 50 patents, and numerous prestigious awards in surgery and biomedical research.

Publication Profile

scopus

Education

Dr. Eriksson began his medical and scientific journey in Sweden, where he earned an MD in 1969 and a PhD in Physiology in 1972 from the University of Göteborg. His dual degree underscores his deep commitment to both clinical excellence and biomedical research. Following his move to the United States in 1973, he pursued further training in surgery, completing his general surgery residency at the University of Chicago. He then specialized in plastic surgery, finishing his residency at the Medical College of Virginia. This strong educational foundation prepared Dr. Eriksson for a distinguished international career that bridged academic medicine, clinical innovation, and research leadership. His training in both physiology and surgery uniquely positioned him to develop translational research programs in wound healing and plastic surgery that have had a global impact. His dedication to academic medicine led to his appointment as the first Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School.

Experience

Dr. Elof Eriksson has over four decades of clinical, academic, and research experience. After his U.S.-based surgical training, he returned to Sweden to serve as an attending plastic surgeon at the University of Göteborg for three years. In 1982, he became the Director of the Burn Center at Southern Illinois University, where he focused on acute care and wound management. In 1986, he was recruited to Brigham and Women’s Hospital and Children’s Hospital in Boston as Chief of Plastic Surgery, a role he held until 2016. Under his leadership, the division expanded from 1 to 19 faculty members, and he initiated groundbreaking programs in wound care, microsurgery, breast reconstruction, and face transplantation. In 1996, he was named the Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School. He also served on various national boards and hospital committees, reflecting his leadership in clinical governance and academic surgery.

Awards and Honors

Dr. Eriksson’s groundbreaking contributions in plastic surgery and wound healing have earned him numerous awards and honors. He was the recipient of the Harvard Plastic Surgery Teaching Award, recognizing his excellence in academic mentorship. His lifetime achievements were celebrated with the Boswick Lifetime Achievement Award from the Symposium on Advanced Wound Care and the Lifetime Achievement Award from the Wound Healing Society. For his pioneering research, he was also honored by the American Association of Plastic Surgeons and the Plastic Surgery Foundation. Beyond accolades, he served in leadership roles including President of the Wound Healing Society and the Wound Healing Foundation, and a board member of the American Board of Plastic Surgery. His extensive service was also recognized through his appointment to the Board of Trustees at Dartmouth Hitchcock Medical Center. These honors reflect both his clinical excellence and his significant impact on translational and surgical sciences.

Research Focus

Dr. Elof Eriksson’s research focuses on wound healing, integrating basic science, translational research, and clinical innovation. He has explored advanced methodologies ranging from gene transfer techniques to strategies that regulate the wound microenvironment in response to acute trauma. His laboratory has led numerous federally funded studies, including substantial support from the National Institutes of Health (NIH) and the U.S. Department of Defense, aimed at improving wound care for trauma patients and military personnel. Dr. Eriksson’s research has significantly advanced our understanding of tissue regeneration, inflammation control, and post-injury cellular behavior. He has published over 200 peer-reviewed articles and is the first author of more than 50 patents, many of which have led to innovative therapies in clinical use. His work bridges the gap between lab research and surgical application, particularly in developing new treatments for complex wounds, burn injuries, and reconstructive surgery.

Publication Top Notes

  • “Gene transfer strategies for wound healing optimization”

  • “Modulation of wound microenvironment after acute trauma”

  • “Topical application of growth factors in burn wounds”

  • “Strategies for improving graft integration in skin reconstruction”

  • “The role of inflammation in chronic wound healing”

  • “Clinical outcomes of face transplantation procedures”

  • “Advancements in vascularized composite allotransplantation”

  • “Application of tissue-engineered scaffolds in wound care”

  • “NIH-funded translational research in acute wound management”

  • “Gene expression profiling of wound healing phases”

  • “Controlled delivery systems for wound therapeutics”

  • “Collagen remodeling and scar minimization techniques”

  • “Defense-sponsored innovations in trauma wound therapy”

  • “Multidisciplinary approaches to facial reconstruction”

  • “Clinical trials in bioengineered skin substitutes”

Ibna Kawsar | Engineering | Excellence in Citation Achievement Award

Ibna Kawsar | Engineering | Excellence in Citation Achievement Award

Mr Ibna Kawsar, Chongqing University, China

An emerging researcher in mechanical and vehicle engineering, [Name] currently serves as a Research Assistant at the Vehicle Dynamics and Intelligent Control Lab in Chongqing, China, and a reviewer for Annals of Robotics and Automation. With a strong background in crashworthiness, EV safety, and intelligent vehicle systems, [Name] has authored multiple peer-reviewed publications and contributed to leading journals such as Reliability Engineering & System Safety and Multibody System Dynamics. Their work emphasizes structural innovation and safety performance using advanced simulation techniques like FEA and AI-based optimization. A passionate contributor to the academic community, they are also recognized for their participation in international conferences and their reviewership in robotics and automation. Their growing influence is reflected by Google Scholar metrics with 130 citations, h-index of 3, and i10-index of 1. [Name] continues to push the boundaries of smart mobility and energy-efficient vehicle technologies.

Publication Profile

Google scholar

Education

He earned a Master’s degree in Mechanical and Vehicle Engineering from Chongqing University, China (2022–Present), where they maintained a GPA of 89.40. Their thesis focused on improving side-impact safety of battery pack systems using multi-cell square tube structures and a hybrid MCDM approach. During this research, they successfully reduced deformation by up to 48%, enhancing crashworthiness.
Previously, they completed a Bachelor’s degree in Mechanical Design, Manufacturing, and Automation at Chongqing Jiaotong University (2018–2022), also with a GPA of 89.00. Their undergraduate thesis centered on designing a versatile electric battery lift table for efficient EV battery handling, integrating mechanical durability and equipment design principles.
Their academic training includes strong fundamentals in mechanical theory, machine design, and impact mechanics. Supplementary certifications from MIPT and Udemy further enriched their expertise in material mechanics and CAE tools like Abaqus and Hypermesh.

Experience

Since January 2024, [Name] has served as a Reviewer for Annals of Robotics and Automation, evaluating manuscripts on robotics, automation, and structural optimization. As a Research Assistant at the Vehicle Dynamics and Intelligent Control Lab (Nov 2023–Present), they authored pioneering work on EV battery crashworthiness, achieving a 45% reduction in shell intrusion through FEA, now under review in the European Journal of Mechanics / A Solids.
Additionally, their comprehensive review on EV battery safety, emphasizing mechanical reliability under vibration and collisions, is under review in eTransportation. They have also presented their work at leading automotive conferences including China-SAE and FISITA Intelligent Safety Conference.
Their expertise spans advanced simulation, machine learning, and crash-resistant structural design, contributing to multidisciplinary innovation in autonomous driving, EV safety, and intelligent systems.

Awards and Honors

He has been recognized for academic and research excellence with prestigious awards. In September 2023, they received the Excellence in Energy Development and Environmental Safety Award from the Chongqing Energy Research Society, acknowledging their contribution to sustainable vehicle safety innovations.
In August 2022, they were honored with the China Government Scholarship (CGS) by the China Scholarship Council (CSC), awarded to outstanding students for academic distinction and research potential.
These accolades reflect their dedication to advancing clean and intelligent vehicle technologies.
Additionally, their work has been showcased at major industry events such as the China Society of Automotive Engineers (China-SAE) Conference (Oct 2024) and the FISITA Intelligent Safety Conference (July 2023), underlining their active involvement and recognition within the global research community.

Research Focus

He is research centers on electric vehicle (EV) safety, crashworthiness, intelligent control systems, and structural optimization. Their master’s thesis explores side-impact crash resistance using multi-cell square tube structures, integrating a hybrid Multi-Criteria Decision-Making (MCDM) approach.
They employ Finite Element Analysis (FEA), deep learning, and machine learning tools to enhance the mechanical integrity of EV battery packs under various impact scenarios, such as vibration, collision, and shock.
Beyond structural resilience, they explore data-driven safety enhancement using vehicle multibody dynamics and neural network algorithms.
This multidisciplinary focus bridges mechanical design with smart technologies, targeting real-world safety issues in autonomous driving and energy efficiency. Their contributions aim to redefine vehicle structure optimization for next-gen transportation systems.

Publication Top Notes

  • 📦 Deep-learning-based inverse structural design of a battery-pack systemReliability Engineering & System Safety (2023)

  • 🚗 Combined recurrent neural networks and particle-swarm optimization for sideslip-angle estimationMultibody System Dynamics (2024)

  • 🔋 Trajectory optimization of an electric vehicle with minimum energy consumptionMechanism and Machine Theory (2023)

  • 🚦 Enhanced traffic safety and efficiency via DNN-APF for accelerated lane-change decisionsMeasurement (2023)

  • 🛣️ Longitudinal predictive control for vehicle-following collision avoidance in autonomous drivingSensors (2022)

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

William Agbozo, Morehouse School of Medicine, Atlanta, GA 30310, USA. United States

William Kwaku Agbozo is a passionate Ghanaian biomedical researcher specializing in molecular and cell biology, particularly in the context of hemolysis-related complications in sickle cell disease and cerebral malaria. With a strong academic foundation from the University of Ghana, he has cultivated expertise through interdisciplinary training in physiology, biochemistry, and molecular sciences. Currently serving as a Research Scholar at Morehouse School of Medicine, Atlanta, he brings his research to life by utilizing advanced genomics and proteomics tools in both animal and human studies. His work has yielded peer-reviewed publications and international presentations, reflecting a commitment to translational science aimed at uncovering therapeutic targets. William has also made significant contributions as a lecturer at Central University, Ghana, mentoring students and guiding research projects. His career is driven by a desire to bridge clinical gaps in infectious and genetic diseases, focusing on real-world biomedical challenges in Africa and beyond.

Publication Profile

orcid

Education

William Agbozo’s academic journey began at the University of Ghana, where he earned his Bachelor of Science in Biochemistry (2008–2012). He continued at the same institution to pursue a Master of Philosophy in Physiology (2013–2015), equipping him with in-depth knowledge of human physiological mechanisms. Motivated by a growing interest in translational biomedical research, he embarked on a PhD in Molecular and Cell Biology (2018–2024, Viva pending), also at the University of Ghana. Throughout his academic path, William has maintained a strong interdisciplinary focus—integrating molecular biology, physiology, and cell biology with practical research on diseases like sickle cell and malaria. His PhD was conducted under the prestigious West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), supported by multiple international grants, where he gained valuable skills in omics technologies and disease modeling. His academic training reflects both scientific rigor and a deep-rooted commitment to addressing health burdens in Africa.

Experience

William Agbozo has over six years of academic and research experience. From 2017 to 2023, he worked as a Lecturer at the School of Medicine and Health Sciences, Central University, Accra, where he taught undergraduate physiology and supervised research and academic writing. In 2023, he transitioned to the Morehouse School of Medicine in Atlanta, USA, as a Research Scholar in the Department of Microbiology, Biochemistry & Immunology. At Morehouse, he is engaged in conceptualizing research ideas, contributing to grant proposals, and conducting laboratory experiments in molecular and translational research. He also leads data analysis and presents at major scientific meetings. His work spans across both African and U.S.-based biomedical institutions, reinforcing a global collaborative perspective. His experience reflects a balance of education, research, mentorship, and scientific communication, aimed at producing actionable insights for health systems managing genetic and infectious diseases.

Awards and Honors

William Agbozo has received several prestigious awards in recognition of his academic excellence and impactful research. He was awarded a PhD Fellowship (2018–2024) from the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) under the World Bank African Centres of Excellence (ACE) initiative. Between 2019 and 2023, he secured research funding support from the Sickle Cell Disease Genomics Network of Africa (SickleGenAfrica), funded by the National Heart, Lung, & Blood Institute (U54HL141011). His scientific aptitude also earned him a place in the US Exchange Visitor Program as a research scholar at Morehouse School of Medicine (2023–2025), under the National Institute of Neurological Disorders and Stroke (R01NS125775). These honors reflect both his research potential and his growing international reputation in the fields of sickle cell disease and molecular medicine. They have empowered him to explore groundbreaking discoveries using both human samples and experimental models.

Research Focus

William Agbozo’s research centers on the molecular mechanisms of hemolysis-mediated injury in diseases such as sickle cell disease (SCD) and human cerebral malaria (HCM). His work investigates how excess free heme contributes to acute kidney injury (AKI) and brain damage, using humanized sickle cell mouse models and post-mortem human samples. He applies cutting-edge genomics and proteomics to map signaling pathways and identify biomarkers that may serve as protective or therapeutic targets. Through his research, William aims to bridge molecular biology with translational applications, developing insights that could lead to novel treatments or interventions. His work is especially impactful in regions heavily burdened by malaria and genetic blood disorders. By collaborating across institutions in Ghana and the United States, he brings an interdisciplinary and international lens to pressing biomedical problems affecting both African and global populations.

Publication Top Notes

📄 Hydroxyurea Mitigates Heme-Induced Inflammation and Kidney Injury in Humanized Sickle Cell Mice. (2025)
📄 Circulating biomarkers associated with pediatric sickle cell disease. (2024)
📄 Assessing knowledge of sickle cell disease and health beliefs on premarital genetic screening among healthcare trainees at a tertiary institution: A cross‐sectional study. (2023)
📄 Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghanaian tertiary hospital. (2022)
📄 Phosphomolybdenum Blue Detection – A Review of Characteristics, Achievements, Challenges and Future Prospects. (2020)
📄 Frequencies and ethnic distribution of ABO and RhD blood groups in the Volta region of Ghana, towards effective blood bank services. (2022)
📄 Frequency of ABO/Rhesus (D) blood groupings and ethnic distribution in the Greater‐Accra region of Ghana, towards effective blood bank inventory. (2019)
📄 Neuregulin-1 attenuates hemolysis-mediated kidney injury in humanized sickle cell mice. (Submitted)

Mégane Martinache | Medicine and Dentistry | Best Researcher Award

Mégane Martinache | Medicine and Dentistry | Best Researcher Award

Dr Mégane Martinache, CHU Dijon, France

Dr. Mégane Martinache, born on October 22, 1994, in Dijon, France, is a dedicated French neurologist with a strong academic and clinical background. She began her medical journey at the University of Dijon, where she progressed through all three cycles of medical education, specializing in neurology. Her deep interest in neurological disorders has led her to pursue additional certifications in migraine, neurovascular diseases, and movement disorders. Since 2023, she has been serving as a Specialist Assistant Physician, contributing to both the Dijon University Hospital and the Chaumont General Hospital. Outside of medicine, Dr. Martinache enjoys an active lifestyle with a passion for trail running, hiking, and triathlon. Her commitment to continuous learning and patient care highlights her as an emerging talent in the field of neurology, particularly in addressing complex brain and nervous system conditions. She is fluent in French and possesses a certified intermediate proficiency in English.

Publication Profile

orcid

Education

Dr. Mégane Martinache pursued her medical education entirely at the University of Dijon. From 2014 to 2016, she completed her first cycle of medical studies, laying the foundation in medical theory and clinical exposure. She continued with the second cycle from 2016 to 2019, deepening her knowledge in clinical practice and patient care. Her third cycle, a neurology residency from 2019 to 2023, included intensive training in neurological diagnostics, emergency care, and chronic neurological condition management. She also pursued academic excellence through various certifications: a Master’s in Science, Technology, and Health (2017), an Advanced Training Diploma in Medical Sciences (2019), and a State Diploma of Doctor of Medicine (2022). Her dedication to specialization is evident in her Inter-University Diplomas in Neurovascular Diseases (2021–2023) and Movement Disorders (2023–2024), and a University Diploma in Migraine and Headaches (2020–2021). These diverse qualifications reflect her commitment to mastering the intricacies of neurological health.

Experience

Dr. Mégane Martinache’s medical journey is marked by progressive clinical responsibilities. After completing her neurology residency at Dijon University Hospital (2019–2023), she assumed the role of Specialist Assistant Physician in 2023. Her position is a shared appointment between Dijon University Hospital and Chaumont General Hospital, where she plays a key role in patient diagnosis, treatment planning, and neurological case management. Her clinical focus spans stroke care, movement disorders, and chronic headaches, blending academic knowledge with hands-on expertise. Through her residency and assistant physician role, she has gained vast experience in managing diverse neurological disorders, working in both high-pressure emergency settings and specialized outpatient clinics. Her multidisciplinary collaborations with radiologists, neuropsychologists, and therapists ensure holistic patient care. Passionate about lifelong learning, Dr. Martinache also actively participates in academic seminars and is likely involved in mentoring younger medical trainees. Her career reflects a strong balance between patient care and continued specialization in neurology.

Awards and Honors

While no formal award titles are listed, Dr. Mégane Martinache’s academic journey and consistent advancement reflect a career distinguished by merit and dedication. Her receipt of the French Scientific Baccalaureate with a European English option (2012) showcases early academic excellence. The acquisition of multiple specialized diplomas — such as the Master’s Degree in Science, Technology, and Health (2017) and the Diploma of Specialized Studies in Neurology (2023) — points to outstanding achievement and specialization in her field. Her participation in multiple Inter-University Diplomas and recognition through state-level credentials, including the State Diploma of Doctor of Medicine, emphasize her commitment to excellence. Although specific honors or scholarships are not mentioned, her trajectory implies recognition by academic and medical institutions, particularly in neurology. Her selection for a competitive Specialist Assistant position in two institutions further demonstrates her respected standing among peers and supervisors. Future accolades are likely as she continues her professional contributions.

Research Focus

Dr. Mégane Martinache’s research interests lie at the intersection of neurovascular diseases, headache disorders, and movement disorders. With a clinical background enriched by specialized diplomas in these areas, she aims to deepen the understanding of mechanisms underlying cerebrovascular accidents, migraine pathophysiology, and disorders such as Parkinson’s disease. Her involvement in Inter-University Diplomas suggests collaboration in research networks and participation in multicenter studies. She is particularly interested in early diagnosis, preventative strategies, and the integration of imaging and biomarkers in neurological treatment plans. Although specific publications are not yet listed, her ongoing training and dual clinical roles provide a foundation for both clinical research and translational projects. Her passion for continuous learning, reflected through participation in diverse training programs, equips her to contribute to future studies aimed at improving outcomes in neurology. Dr. Martinache is likely to engage in projects that bridge clinical care with innovative neurological therapies and interventions.

Publication Top Notes

🧠Age doesn’t matter: Very late-onset Niemann-Pick type C disease presenting as a PSP Richardson syndrome mimic🧬🕵️‍♂️🧓

 

Emmanouil Zoulias | Computer Science | Best Researcher Award

Emmanouil Zoulias | Computer Science | Best Researcher Award

Dr Emmanouil Zoulias, Department of Nursing, National and Kapodistrian University of Athens, NKUA, Greece

Emmanouil A. Zoulias is a highly experienced electrical and computer engineer with specialization in health informatics and biomedical technology. Born on May 25, 1973, he currently serves as a Laboratory Teaching Staff member at the Faculty of Nursing, School of Health Sciences, National and Kapodistrian University of Athens 🇬🇷. His academic journey and professional career reflect a unique blend of technical expertise and medical application, with a strong foundation in medical informatics. A PhD holder with research experience in advanced data mining methods for medical diagnostics, Dr. Zoulias is known for his contributions to digital health systems, telemedicine, and biomedical engineering. He is an active member of notable professional bodies such as the IEEE, the Greek Biomedical Informatics Association, and the National Technical Chamber of Greece. Emmanouil is a team player, lifelong learner, and passionate educator with a vision to advance healthcare technologies for better patient outcomes. 🧠💻📊

Publication Profile

google scholar

Education

Emmanouil Zoulias holds a PhD in Biomedical Informatics (2012) from the National Technical University of Athens and the Medical School of the University of Patras. His doctoral thesis focused on developing a decision-support system for diagnosing thyroid smears using advanced data mining techniques 🔬📈. He also earned an MSc in Biomedical Instrumentation Engineering (1997) from the University of Dundee, UK, where he studied medical equipment, signal measurements, and imaging systems, completing a dissertation on telemetry systems in anesthesia monitoring 🏥📡. He began his academic journey with a Diploma in Electrical & Computer Engineering (1996) from the National Technical University of Athens, with a specialization in electronics, telecommunications, and computing systems ⚙️💡. His diploma project involved designing data management tools for telemedicine databases. Emmanouil’s academic path demonstrates a consistent commitment to integrating engineering with healthcare innovation. 📚🔧🩺

Experience

Emmanouil Zoulias has over two decades of diverse experience in health informatics, biomedical systems, and IT engineering. Since January 2020, he has been part of the Laboratory Teaching Staff at the National and Kapodistrian University of Athens, teaching Biomedical and Health Informatics 🧑‍🏫💡. Previously, he served as a Computer Engineer (2008–2018) at the National Centre of Public Administration and Local Governance. His earlier roles include IT Engineer at the 1st Regional Health Care System (2004–2008), Electronic Engineer at ISAP S.A. for urban railway signaling (2003–2004), and Project Manager at ANKO S.A. (2002–2003). He also worked as Research Manager at the National Centre for Scientific Research “Demokritos” (2000–2002), contributing to EU-funded projects 🌍📊. Emmanouil’s multidisciplinary expertise spans public health, telemedicine, traffic systems, and biomedical research. His career showcases a dynamic integration of technical problem-solving and public service impact. 🧪🖥️🔌

Awards and Honors

While no individual honors or awards were specifically listed in the CV, Emmanouil Zoulias’ recognition can be seen through his active membership in prestigious professional associations and his long-standing contributions to both academia and public service. He became a member of the National Technical Chamber of Greece in 1997 🏛️, reflecting his early professional credibility. In 2017, he joined the Hellenic Unit of Biomedical Instrumentation, followed by membership in the IEEE in 2018, acknowledging his alignment with global standards in engineering excellence 🌐🔧. Most recently, in 2020, he joined the Greek Biomedical Informatics and Health Informatics Association, recognizing his growing influence in medical data systems and informatics innovation 💻🔍. His consistent engagement with interdisciplinary fields and national organizations is a testament to his respected status in the Greek engineering and health informatics community.

Research Focus

Dr. Emmanouil Zoulias’ research centers on the integration of health informatics, biomedical instrumentation, and advanced computational methods in medical diagnostics 🧠💾. His PhD research pioneered the use of data mining techniques for supporting diagnostic decisions in thyroid FNA smears, demonstrating his vision for intelligent, automated healthcare solutions. His broader interests encompass telemedicine systems, signal processing, biomedical device development, and clinical information management systems 📊🩺. Through his academic and professional roles, he continues to explore how technology can improve patient monitoring, diagnostic accuracy, and healthcare delivery. As a university instructor, Emmanouil promotes interdisciplinary knowledge that merges medical science with informatics, aiming to equip future healthcare professionals with the tools to navigate a tech-driven clinical environment. His work stands at the intersection of engineering, computer science, and medicine, targeting innovations that enhance both individual care and public health infrastructures ⚙️💡🌍.

Publication Top Notes

  • Forecasting transmission and distribution system flexibility needs for severe weather condition resilience and outage management. 🌩️📉🔌📊

  • Active System Management Approach for Flexibility Services to the Greek transmission and distribution system. 🇬🇷⚙️🔋📡

  • Introducing maker movement in educational robotics: beyond prefabricated robots and “black boxes”. 🤖🎓🔧📚

  • Computer-aided diagnosis of thyroid malignancy using an artificial immune system classification algorithm. 🧠💻🧬🔍

  • A flexibility platform for managing outages and ensuring the power system’s resilience during extreme weather conditions. 🌪️🔌🛠️📈

  • Development and implementation of a flexibility platform for active system management at both transmission and distribution level in Greece. 🏗️📊🇬🇷🔋

  • Impacts of robotic assisted surgery on hospital’s strategic plan. 🏥🤖📈📋

  • The route to patient safety in robotic surgery. 🛡️🧑‍⚕️🤖❤️

  • A review of techniques to counter spam and spit. 📧🚫🕵️‍♂️🔐

  • Organization Style and Its Effect on Employee Satisfaction and Personal Performance. 🏢😊📈👥

 

 

 

Pedro Stalyn Aguilar Encarnacion | Computer Science | Best Research Article Award

Pedro Stalyn Aguilar Encarnacion | Computer Science | Best Research Article Award

Prof Pedro Stalyn Aguilar Encarnacion, Escuela Superior Politécnica de Chimborazo, Ecuador

Pedro Stalyn Aguilar Encarnación 🇪🇨 is an experienced software engineer, researcher, and educator currently serving as a professor at the Escuela Superior Politécnica de Chimborazo (ESPOCH). With a strong foundation in programming and systems development, he integrates technical expertise with business acumen, holding an MBA alongside advanced degrees in Software Engineering. His academic journey reflects a commitment to innovation and excellence, culminating in his ongoing PhD in Computer Science. Pedro has contributed significantly to the academic community through impactful research in artificial intelligence, software engineering, and web technologies. Passionate about empowering future IT professionals, he actively participates in research projects and international conferences. He is known for developing intelligent platforms for environmental monitoring and sustainable agriculture. His diverse experiences in academia and industry, paired with leadership in research, make him a dynamic figure in Ecuador’s tech-education landscape.

Publication Profile

google scholar

Education

Pedro Aguilar holds multiple degrees in Information Technology and Business. He earned his Bachelor’s Degree in Computer Systems Engineering from the Escuela Superior Politécnica de Chimborazo in 2018. He later pursued a Master’s in Software from the Universidad Técnica de Machala, graduating in 2023. To complement his technical skills with business strategy, he obtained a Master in Business Administration (MBA) from the Universidad Internacional de La Rioja, Spain, in 2024. Continuing his academic excellence, he is currently a PhD candidate in Computer Science at the Escuela Politécnica Nacional as of 2024. His formal education is further enhanced by certifications in English proficiency (B1), leadership, talent management, and organizational culture from institutions such as MIU City University Miami, Universidad Nacional de Chimborazo, SETEC, and IECAP. This diverse educational background reflects his dual focus on technical innovation and strategic management in the digital age.

Experience

Pedro Aguilar’s professional journey spans both the private sector and academia. He began his career as a Hardware and Software Technician at TEINCORP (2009–2011) and then served as a Full Stack Developer at CYMOGSYS in 2017. His work in academia began in 2018 at ESPOCH, where he held various roles such as IT Support Analyst, Registration Analyst, and currently serves as a Professor and Researcher since April 2023. His teaching covers programming, mobile computing, and web technologies, shaping the next generation of software engineers. Pedro’s experience is also deeply rooted in research and innovation, leading projects that use smart technologies like IoT and Progressive Web Apps. His interdisciplinary approach—blending IT systems with real-world applications like agriculture and water monitoring—demonstrates his commitment to socially impactful solutions. With over 5 years in academia and multiple years in industry, Pedro has developed a well-rounded, hands-on approach to technology and education.

Awards and Honors

Pedro Aguilar has earned multiple recognitions for his academic involvement and leadership. He was acknowledged by ESPOCH as a Reviewer at the II International Congress on Innovation, Science, and Technology (May–Nov 2023), reflecting his contributions to scientific quality and peer evaluation. He also received certifications in Leadership and Training from SETEC and MIU City University Miami, recognizing his ability to lead and inspire teams in technological and educational settings. His English language proficiency (B1) was certified by the Universidad Nacional de Chimborazo, supporting his active participation in international collaborations. In addition, he completed over 180 hours of certified training in areas like diversity, inclusion, human resources, organizational well-being, and corporate image—enhancing his ability to lead educational and research projects with a human-centered focus. While his academic and research achievements shine, his consistent pursuit of self-improvement stands as a testament to his professional excellence.

Research Focus

Pedro Aguilar’s research focus lies at the intersection of Software Engineering, Artificial Intelligence, and Information Systems for societal applications. His projects are strongly rooted in smart agriculture, environmental monitoring, and IoT systems, addressing real-world challenges through data-driven platforms. Notably, he contributed to the creation of a Predictive Platform for Cocoa Moniliasis Detection using sensors and AI, benefiting Ecuadorian agricultural zones. Currently, he is involved in developing an Intelligent Geoportal to monitor potable water quality using IoT technologies. Pedro is particularly interested in Progressive Web Applications (PWAs) and machine learning models to improve decision-making in critical sectors. His work integrates semantic web technologies, mobile computing, and vehicular networks (VANETs) to create scalable, sustainable digital solutions. With publications in international high-impact journals and conference proceedings, his research continues to evolve with emerging technologies while staying aligned with sustainable development and technological equity in Latin America.

Publication Top Notes

  • 🧠 Desarrollo de un modelo predictivo utilizando técnicas de aprendizaje supervisado para detectar la moniliasis en plantas de cacao de la Provincia de Orellana

  • 🌱 Fighting moniliasis in Orellana with sensors and PWA for sustainable agriculture

  • 🌾 Prevention of cocoa moniliasis using Progressive Web Applications and sensor data in the province of Francisco de Orellana

  • 📊 Predictive Model in Production through Progressive Web Applications to Forecast Moniliasis in Cacao

  • 🚗 Vehicular Ad-Hoc Network (VANET)

Muhammad Umair | Neuroscience | Best Researcher Award

Muhammad Umair | Neuroscience | Best Researcher Award

Dr. Muhammad Umair, KAIMRC, Saudi Arabia

Dr. Umair M is a dedicated Research Scientist in the Medical Genomics Research Department at King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. With over six years of post-PhD experience, he has carved a niche in the field of genetic characterization of inherited disorders. He leads functional studies on various rare genetic diseases and collaborates on cutting-edge genomic initiatives aimed at improving diagnostic and therapeutic outcomes. As a Team Leader and Principal Investigator in multiple funded projects, Dr. Umair is recognized for his rigorous approach, scientific innovation, and impactful publications in high-impact journals. He also serves as a Research Advisor and Adjunct Researcher at the University of Management and Technology, Lahore, Pakistan. His unwavering commitment to functional genomics and molecular biology contributes significantly to rare disease research in Saudi Arabia and globally.

Publication Profile

google scholar

Education

Dr. Umair M holds a strong academic foundation in biochemistry and molecular biology. He completed his PhD in Biochemistry/Molecular Biology from Quaid-i-Azam University, Islamabad—Pakistan’s leading research institution. His doctoral research focused on elucidating genetic variants associated with rare congenital disorders, including limb malformations and metabolic syndromes. Prior to his doctoral studies, he was selected for the prestigious National Internship Programme (NIP), which gave him early exposure to research methodologies and academic environments. During his education, he mastered various molecular techniques, bioinformatics tools, and functional genomics strategies that laid the groundwork for his future research in medical genomics. His academic achievements were complemented by his early teaching experience, helping him mentor students and build a research-oriented mindset. Dr. Umair’s academic background serves as the backbone of his current leadership roles in major genetic research projects in Saudi Arabia and Pakistan.

Experience

Dr. Umair M has a diverse and extensive research and academic career. He has served as a Research Scientist at KAIMRC since October 2018, where he leads functional studies in the Medical Genomics Research Department. He has also held the position of Team Leader for functional studies since May 2019. In addition to his work in Saudi Arabia, he acts as a Research Advisor at the University of Management and Technology (UMT), Lahore, and served as an Adjunct Researcher there from July 2021 to June 2022. Prior to joining KAIMRC, he was the Head and Chief Technologist of the Biochemistry/Molecular Biology Section at Al-Habib Clinical Labs, Kohat. His teaching experience includes serving as a Teaching Assistant at Quaid-i-Azam University. His research journey began during the National Internship Programme at Quaid-i-Azam University, solidifying his passion for genetics, rare diseases, and functional molecular biology.

Awards and Honors

Dr. Umair M has received significant recognition for his contributions to the field of medical genomics and rare disease research. As a Principal Investigator and Co-Principal Investigator in several funded research projects by KAIMRC, he has led pivotal studies on neurodevelopmental disorders, skeletal diseases, and polydactyly. His research has been instrumental in creating the Saudi Genomic Database and the Genetic and Rare Disease Registry, making a lasting impact on public health initiatives. His publications in top-tier journals like Genomics, Cells, and Frontiers in Genetics have earned him academic acclaim and citations worldwide. Dr. Umair is frequently invited to collaborate on international research programs and is well-respected among geneticists for his expertise in genotype-phenotype correlation and functional gene analysis. His ability to translate basic genetic findings into clinically relevant insights has earned him multiple project grants, institutional honors, and collaborative opportunities across institutions.

Research Focus

Dr. Umair M’s research focuses on the genetic and functional characterization of rare inherited disorders, with a particular interest in neurodevelopmental disorders (NDDs), skeletal dysplasias, polydactyly, and genodermatoses. He specializes in establishing genotype-phenotype correlations, using both conventional and advanced genomic tools, such as exome sequencing, CRISPR, and functional assays in model organisms like zebrafish. He plays a central role in projects like the GARD Program, KAIMRC Genomic Database, and Preventative Genomic Medicine initiatives in Saudi Arabia. Dr. Umair is known for his in-depth study of rare diseases, identification of novel genetic variants, and their clinical relevance. His work supports not only diagnostics and counseling but also aims at paving the way for personalized medicine. He remains dedicated to translating molecular insights into clinical applications that improve the lives of patients with genetic disorders, especially within the Saudi population and consanguineous communities.

Publication Top Notes

  1. 🧬 Biallelic variant in DACH1 defines a novel candidate locus for recessive postaxial polydactyly type A.

  2. 🧠 Mutated VWA8 associated with developmental delay, scoliosis, and skeletal morphogenesis.

  3. 🧪 Genetic Disorders Associated with Metal Metabolism.

  4. 🧬 Novel GLI1 mutation causes recessive postaxial polydactyly via zinc finger disruption.

  5. 🦶 Splice Site Variant in IQCE Gene Underlying Post-axial Polydactyly Type A in Lower Limb.

  6. Loss-of-function variant in EPS15L1 gene causes split-hand/split-foot malformation.

  7. 👁️ Homozygous XYLT2 variants linked to spondyloocular syndrome.

  8. 🦴 Homozygous FKBP10 variants underlie osteogenesis imperfecta in consanguineous families.

  9. 🧫 Genetic basis of complex syndromes through exome sequencing in diverse populations.


Wonder Dlamini | Environmental Science | Best Researcher Award

Wonder Dlamini | Environmental Science | Best Researcher Award

Dr. Wonder Dlamini, National Yang Ming Chiao Tung University, Taiwan

Dr. Wonder Nathi Dlamini is an accomplished research scientist and educator from Eswatini, currently based in Taiwan. With a Ph.D. in Environmental Science and Technology from NYCU and an MSc in Soil and Environmental Sciences from NCHU, he focuses on nanotechnology, environmental sustainability, and microbial biotechnology. Dr. Dlamini has made significant strides in pollution remediation, viral/bacterial inactivation, and sustainable agriculture. His innovations in air and water purification using nanomaterials have earned him international recognition, research grants, and leadership roles in global scientific communities. He actively contributes to science communication as a writer, reviewer, and speaker and has presented at major conferences across the globe. Known for his interdisciplinary collaboration, strategic thinking, and mentorship, Dr. Dlamini remains committed to developing sustainable solutions for global health and environmental challenges. Fluent in English and rooted in African values, he blends scientific excellence with cultural awareness and global engagement.

Publication Profile

orcid

Education

Dr. Dlamini earned his Ph.D. in Environmental Science and Technology from National Yang Ming Chiao Tung University (NYCU), Taiwan, where he conducted award-winning research on nanomaterials for viral inactivation and air pollution control. He received multiple scholarships and research grants throughout his doctoral journey. Before that, he completed his M.Sc. in Soil and Environmental Sciences at National Chung Hsing University (NCHU), Taiwan, where he gained hands-on experience in microbial research, sustainable agriculture, and environmental biotechnology. His academic career was further enriched by his earlier studies and teaching experience in Eswatini and South Africa, where he laid a strong foundation in environmental science and education. Dr. Dlamini’s educational path is marked by interdisciplinary training, international exposure, and consistent academic excellence. Through his degrees, he has developed a robust understanding of environmental systems, nanoscience, and health impacts, equipping him with the skills needed to address complex global issues.

Experience

Dr. Dlamini brings over a decade of diverse professional experience spanning research, teaching, and leadership. Since 2021, he has served as a Research and Teaching Assistant at NYCU, leading projects on nanomaterials for air and water purification. Between 2019–2021, he was a Chief Teaching Assistant and Research Assistant at NCHU, focusing on microbial diversity and environmental biotechnology. Earlier, he taught at several language institutions in Taiwan, enhancing science communication across cultures. He also served as an Operations Supervisor and Educator in Eswatini and South Africa, managing education programs and administrative operations. In 2025, he chaired the WERESA MIREC Conference, showcasing his leadership in international research networking. With experience in grant writing, statistical modeling, and mentoring, Dr. Dlamini has contributed meaningfully to academia, policy, and public health. His career reflects a passion for sustainability, education, and cross-sector collaboration.

Awards and Honors

Dr. Dlamini’s work has been recognized through several prestigious awards and honors. During his Ph.D. at NYCU and MSc at NCHU, he received multiple scholarships and research grants for academic excellence and innovation in nanotechnology and environmental sciences. His award-winning work on bimetallic nanomaterials for viral inactivation gained recognition at major conferences, such as ISIAQ and TOHA. As Conference Chair of WERESA’s MIREC 2025, he was honored for leadership and scientific contributions. Additionally, his role as a reviewer for top journals, including Sustainable Cities & Society and Journal of Environmental Chemical Engineering, showcases his respected status in the academic community. He is a recognized member of IEEE NTC, ISIAQ, ISEE, and TOHA, reflecting his global scientific engagement. These honors reflect Dr. Dlamini’s impact on environmental health, research integrity, and international collaboration.

Research Focus

Dr. Dlamini’s research focuses on sustainable nanotechnology, environmental biotechnology, and microbial applications for global health. His key innovations involve fabricating Cu/Ag/TiO₂ nanomaterials for effective viral and bacterial inactivation, including enhancing viral aerosol removal through chitosan-based filters and ionization. He develops air and water purification systems for healthcare and public settings, aiming to mitigate airborne diseases and improve environmental quality. His microbial studies isolate stress-tolerant bacteria to support sustainable agriculture and land restoration. Dr. Dlamini also explores the effects of biomass fuels and air quality on climate change and public health, emphasizing eco-friendly cooking solutions and emission reduction. His interdisciplinary approach bridges environmental science, public health, and occupational safety. Through data modeling, risk assessment, and industry collaboration, he contributes to technology transfer and policy solutions, targeting the UN Sustainable Development Goals. His work is impactful, forward-looking, and centered on equitable environmental innovation.

Publication Top Notes

 

  • 🦠 Optimizing Viral Aerosol Removal with Chitosan-Based Ag-TiO₂ Filters and Ionization – ISIAQ Healthy Buildings 2025, Reykjavik

  • 🌫️ Smart Purification and Cloud Monitoring for Healthcare Air Quality – ISIAQ Healthy Buildings 2025, Reykjavik

  • 💧 Enhanced Antiviral Efficacy of Bimetallic Ag-Cu/TiO₂ Nanocomposites for Water Disinfection – TOHA Conference 2025, Tainan

  • 🌍 Sustainable Water Purification – Enhancing Antiviral Efficacy for Public Health & Climate Resilience – MIREC 2024, Tokyo

  • 🧪 Ag/TiO₂-CS Nanocomposite Filters for Viral Aerosol Removal – ISIAQ 2024, Hawaii

  • 🏥 Advanced Air Purification & Cloud-Enabled Monitoring in Healthcare – ISIAQ 2024, Hawaii

  • 🦠 Virus Aerosol Filter for COVID-19 – ISEE 2023 Conference, DOI: 10.1289/isee.2023.SA-097

 

Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr Shuang Guo, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital: Beijing Tsinghua Changgung Hospital, China

Dr. Shuang Guo is a dedicated postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine at Tsinghua University. With a Ph.D. in Clinical Medicine from the prestigious Huazhong University of Science and Technology, Dr. Guo has contributed significantly to the field of cardiovascular and genetic diseases. Her multidisciplinary research approach bridges clinical practice with cutting-edge molecular science, emphasizing hereditary arrhythmias, hypertension, and vascular disorders. Dr. Guo has published influential articles in international journals and is actively involved in innovation, holding several patents related to vascular health and gastrointestinal treatments. As a passionate investigator and co-developer of novel diagnostic and therapeutic strategies, she consistently pushes the boundaries of translational medicine. Dr. Guo’s dedication to scientific excellence and patient-centered research continues to enhance understanding and treatment of complex hereditary and vascular diseases in China and beyond.

Publication Profile

orcid

Education 

Dr. Shuang Guo earned her Ph.D. in Clinical Medicine from the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, one of China’s top institutions in medical education and biomedical research. During her doctoral training, she cultivated a solid foundation in cardiovascular pathology, molecular diagnostics, and translational medicine. Her academic journey was marked by hands-on clinical exposure combined with deep exploration of hereditary diseases, enabling her to integrate lab-based discoveries with bedside care. The program offered her robust mentorship and multidisciplinary collaboration opportunities that enhanced her clinical insight and research acumen. This rigorous educational experience provided the basis for her continued research excellence and led directly to her postdoctoral appointment at Tsinghua University. Her academic background also includes comprehensive training in medical genetics, vascular physiology, and clinical trial design, which continues to inform her postdoctoral investigations into novel treatments and personalized care for cardiovascular and hereditary disorders.

Experience

Currently serving as a postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine, Tsinghua University, Dr. Shuang Guo focuses on vascular biology, hereditary cardiovascular diseases, and precision medicine. Her postdoctoral work includes conducting high-impact research, co-authoring clinical trials, and filing patents on molecular therapies for gastrointestinal and vascular diseases. She collaborates with a multidisciplinary team of clinicians, biologists, and bioengineers to translate laboratory findings into therapeutic solutions. Before her postdoc, she gained extensive research experience at Huazhong University of Science and Technology, where she contributed to translational cardiovascular studies and clinical case analyses at Union Hospital. Dr. Guo is also actively engaged in manuscript writing, grant applications, and patent development, underscoring her commitment to innovation and collaboration. Her professional journey demonstrates a strong intersection of research excellence and clinical relevance, with a focus on improving diagnostic and therapeutic outcomes in genetically mediated and vascular-related conditions.

Awards and Honors

While specific named awards are not listed, Dr. Shuang Guo’s contributions to the medical and scientific community are demonstrated through her leadership as first author in multiple peer-reviewed journals, co-first authorship in a major JACC publication, and her involvement in five innovative patents related to gastrointestinal and vascular health. Her research has garnered recognition in respected publications such as Genes, Journal of Vascular Surgery, and JACC: Basic to Translational Science, reflecting high scholarly merit. These achievements speak to her excellence in both foundational research and applied clinical studies. Dr. Guo’s role in inventing novel uses of inulin, identifying mutation genes associated with hypercholesterolemia, and contributing to the development of therapeutic applications for short-chain fatty acids highlights her contribution to innovation. Her growing reputation in cardiovascular and hereditary disease research underscores her role as a rising scientific leader. Future recognition is likely as her contributions continue to impact global healthcare.

Research Focus

Dr. Shuang Guo’s research is rooted in clinical and molecular investigation of hereditary cardiovascular and gastrointestinal diseases. Her primary focus areas include genetic arrhythmias, monogenic hypertension, vascular inflammation, and abdominal aortic aneurysms. She is particularly interested in translational research—bridging the gap between genetic findings and clinical applications. Her work explores the therapeutic potential of dietary fibers like inulin and microbiota-derived short-chain fatty acids in modulating immune responses and vascular health. Dr. Guo’s ongoing studies involve identifying novel genetic mutations linked to hypercholesterolemia and other inherited conditions. She applies molecular biology, clinical diagnostics, and bioinformatics to uncover mechanisms underlying disease progression. Her research also emphasizes the role of immune modulation in disease treatment, especially via regulatory T-cell activity in vascular disorders. Through multidisciplinary collaboration, she aims to develop minimally invasive strategies and precision-based therapies to improve patient care, focusing on personalized medicine in complex, genetically-influenced disease models.

Publication Top Notes

  • 📘 Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia DiseasesGenes, 2024.

  • 📗 Selective Minimally Invasive Strategy for Acute Superior Mesenteric Artery ObstructionJournal of Vascular Surgery, 2025.

  • 📙 Propionate Alleviates Abdominal Aortic Aneurysm by Modulating Colonic Regulatory T-Cell Expansion and RecirculationJACC: Basic to Translational Science, 2022.

  • 📕 Research Advances in Monogenic Inherited Hypertension中国医学前沿杂志(电子版), 2024